Loading
Latest filing published 06 Aug 2020 for Veritas Pharma Inc., €20k.
This profile gathers the share dealings of Nicholas Standish in Veritas Pharma Inc. We count 3 filings; the first trade dates from 20 November 2018 and the latest from 30 July 2020.
In open-market terms, that means 1 purchase worth €20k on one side and 1 sale worth €1,447 on the other. The net balance comes to €18k on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2020, the count stands at 1 purchase and 1 sale.
On 6 August 2020 came the latest disclosure, an open-market purchase for €20k in Veritas Pharma Inc. Between a trade and the moment it shows up on SEDI, the median delay is 7 days. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations